Exchange of Letters Between the Food and Drug Administration and the Australian Therapeutic Goods Administration

Краткое содержание

The Food and Drug Administration (FDA) is providing notice of an exchange of letters (EOL) between FDA and the Australian Therapeutic Goods Administration. The purpose of the EOL is to facilitate the exchange of documents and information concerning a drug or biological preparation that is considered for orphan status.